DELIVERY MODELS & SPECIALIST SERVICES

Full-service, FSP, central labs, in-home care, or trial rescue?

Biotech sponsors differ on how much oversight they keep in-house. Reviewed CRO pages split across end-to-end outsourcing, FSP staffing, central laboratory anchors, decentralized/in-home visits, and mid-trial rescue.

ICON plc

Accellacare in-home clinical services — all phases

Vendor page claim tied to Accellacare in-home services; does not establish general CRO phase experience, sponsor-specific delivery or outcomes.

Medpace

full-service, single-vendor outsourcing with wholly-owned Central Labs, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab and CTMS

Vendor-stated full-service model; FSP availability not offered/stated on homepage.

Parexel

Integrated clinical development with Site Alliance Network, decentralized trial (DCT) elements, regulatory strategy, clinical logistics, pharmacovigilance

Vendor service statement; protocol-level site availability requires verification.

Syneos Health

Full-service outsourcing (FSO) and Functional Service Provider (FSP 360)

Vendor offers both full-service and FSP delivery models.

Fortrea

full service and FSP clinical development with FDA Diversity Action Plan support

Vendor service statement; does not specify individual trial phase exclusions.

Thermo Fisher Scientific, PPD clinical services

full-service partnerships, functional service partnerships (FSP), and comprehensive laboratory services

Vendor service statement; specific indication/team availability unverified.

Labcorp Drug Development

nonclinical development, central lab services (100+ countries), and companion diagnostics (distinct lab/enablement focus)

Current biopharma page foregrounds laboratory, nonclinical, and CDx services rather than standalone full-service CRO trial management.

Worldwide Clinical Trials

Phase I-IV trial execution, RWE, and Transition Studies (mid-trial rescue)

Vendor markets mid-trial transition/rescue capability.

Precision for Medicine

Full-service CRO and FSP services with integrated translational/biomarker science and Precision labs

Vendor service statement.

Veristat

specialty CRO combining regulatory advisory, biostatistics/InStat, clinical operations, DCT, and clinical trial rescue

Vendor service statement.

Premier Research

global full-service CRO with clinical research and consulting across the development lifecycle

Homepage statement only; therapeutic areas and specific trial phases sit on linked subpages not captured here.

Indero

dual-focus specialty CRO (formerly Innovaderm) with affiliated clinical research unit for North America/global trials

Headquartered in Montreal, Canada with North America trial capabilities.

Kapadi

global full service and FSP oncology/CGT CRO

Vendor service statement; specific trial phases not enumerated on homepage.

PharPoint

Full-service Phase II-IV CRO covering site feasibility, clinical operations, data management, and biostatistics

Vendor service statement; notes APAC CRO partner network alongside US work.

Proxima CRO

Biotech and MedTech CRO covering drugs, medical devices, and diagnostics (regulatory strategy, quality systems, clinical trials, RWE)

Mixed MedTech and biotech scope; confirm pure-biotech Phase II/III drug trial depth separately.

Protocol and handoff checks for delivery models

← Back to the 16-CRO overview

ICON’s general operations go beyond in-home visits

Keep a trial’s visit model separate from the functions you are outsourcing.

ICON · trial delivery

ICON describes traditional, decentralized and hybrid trial models on its clinical-operations page.

These describe visit/delivery models, not evidence that all functions are included in one quoted contract. Source & date